Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9928 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9103 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9073 |
High Similarity |
NPD7075 |
Discontinued |
0.9014 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9014 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9007 |
High Similarity |
NPD1510 |
Phase 2 |
0.9 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8951 |
High Similarity |
NPD1549 |
Phase 2 |
0.8944 |
High Similarity |
NPD2796 |
Approved |
0.8933 |
High Similarity |
NPD6801 |
Discontinued |
0.8926 |
High Similarity |
NPD4380 |
Phase 2 |
0.8912 |
High Similarity |
NPD1512 |
Approved |
0.8857 |
High Similarity |
NPD1240 |
Approved |
0.8816 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8797 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8776 |
High Similarity |
NPD6799 |
Approved |
0.8776 |
High Similarity |
NPD1511 |
Approved |
0.875 |
High Similarity |
NPD2801 |
Approved |
0.8742 |
High Similarity |
NPD7411 |
Suspended |
0.8732 |
High Similarity |
NPD1607 |
Approved |
0.8693 |
High Similarity |
NPD3817 |
Phase 2 |
0.8684 |
High Similarity |
NPD1934 |
Approved |
0.8636 |
High Similarity |
NPD3882 |
Suspended |
0.8627 |
High Similarity |
NPD7819 |
Suspended |
0.8581 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6599 |
Discontinued |
0.8503 |
High Similarity |
NPD2800 |
Approved |
0.8491 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8491 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8418 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8378 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8255 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8235 |
Intermediate Similarity |
NPD920 |
Approved |
0.8224 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8219 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8217 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8194 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.816 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8137 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8113 |
Intermediate Similarity |
NPD3749 |
Approved |
0.811 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8108 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8108 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8105 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8105 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8105 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8105 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8063 |
Intermediate Similarity |
NPD919 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7964 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7867 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7823 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7808 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7806 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7792 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7724 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7718 |
Intermediate Similarity |
NPD943 |
Approved |
0.7692 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7632 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7627 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7534 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3267 |
Approved |
0.745 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1201 |
Approved |
0.732 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD447 |
Suspended |
0.732 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7268 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5889 |
Approved |
0.725 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD411 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7232 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD17 |
Approved |
0.7183 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7159 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7124
|
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |